Moderna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock soars 100%
Published: 2026-08-19
The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.
Originally sourced from cnbc